BioLife Solutions, Inc. (NASDAQ:BLFS) had its price objective upped by investment analysts at Maxim Group from $6.00 to $7.00 in a note issued to investors on Tuesday. The brokerage presently has a “buy” rating on the medical equipment provider’s stock. Maxim Group’s target price would indicate a potential upside of 32.33% from the company’s previous close.
Separately, Janney Montgomery Scott raised BioLife Solutions from a “neutral” rating to a “buy” rating and raised their price objective for the company from $2.62 to $5.00 in a research report on Wednesday, July 5th.
BioLife Solutions (NASDAQ:BLFS) traded down 4.91% during midday trading on Tuesday, hitting $5.03. 868,138 shares of the company were exchanged. The stock’s market capitalization is $66.54 million. The firm’s 50-day moving average price is $4.36 and its 200-day moving average price is $2.86. BioLife Solutions has a one year low of $1.43 and a one year high of $5.91.
BioLife Solutions (NASDAQ:BLFS) last announced its quarterly earnings data on Thursday, August 10th. The medical equipment provider reported ($0.06) EPS for the quarter, meeting the consensus estimate of ($0.06). The business had revenue of $2.56 million during the quarter, compared to analyst estimates of $2.40 million. BioLife Solutions had a negative return on equity of 64.98% and a negative net margin of 63.71%. Equities research analysts anticipate that BioLife Solutions will post ($0.24) earnings per share for the current year.
WARNING: “BioLife Solutions, Inc. (BLFS) PT Raised to $7.00 at Maxim Group” was originally published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this story on another domain, it was copied illegally and republished in violation of US & international trademark & copyright laws. The legal version of this story can be read at https://www.chaffeybreeze.com/2017/09/19/biolife-solutions-inc-blfs-pt-raised-to-7-00-at-maxim-group.html.
BioLife Solutions Company Profile
BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.
Receive News & Ratings for BioLife Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.